0000899243-20-003793.txt : 20200210
0000899243-20-003793.hdr.sgml : 20200210
20200210160648
ACCESSION NUMBER: 0000899243-20-003793
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200210
DATE AS OF CHANGE: 20200210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Cruz Cony
CENTRAL INDEX KEY: 0001797727
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 20591929
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0001490978
Schrodinger, Inc.
SDGR
0001797727
D'Cruz Cony
C/O SCHRODINGER, INC.,
120 WEST 45TH STREET, 17TH FLOOR
NEW YORK
NY
10036
0
1
0
0
See Remarks
Stock Option (right to buy)
17.00
2020-02-10
4
A
0
33443
0.00
A
2030-02-04
Common Stock
33443
33443
D
The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.
Executive Vice President and Chief Business Officer
/s/ Yvonne Tran, as attorney-in-fact for Cony D'Cruz
2020-02-10